About BioNK

Translational biotechnology, built from Brazil

BioNK operates at the interface of immunology, cell engineering, advanced therapy manufacturing, regulatory strategy and clinical translation.

Mission

To develop scientifically rigorous, regulator-ready NK and CAR-NK cell therapy platforms for high-need oncology indications.

Vision

To help build a globally credible advanced therapy ecosystem from Brazil — connecting world-class science, regulated manufacturing, clinical development and responsible patient access.

Values

How we operate.

Scientific integrity

Regulatory discipline

Patient safety

Translational focus

Manufacturing realism

IP protection

Responsible access

Global collaboration

Leadership

Operating team.

Profiles will be updated as team disclosures are confirmed for public release.

Chief Executive Officer

Leadership Profile

Cell therapy operations · Strategy · Brazil ATMP ecosystem

Chief Scientific Officer

Leadership Profile

Immunology · NK cell biology · Translational oncology

Head of Manufacturing & CMC

Leadership Profile

GMP/BPF cell therapy · Process development · Cryopreservation

Head of Clinical & Regulatory

Leadership Profile

Clinical development · ANVISA / EMA / FDA strategy